Non-transferable risk and Remittance: Difference between pages

From ACT Wiki
(Difference between pages)
Jump to navigationJump to search
imported>Doug Williamson
(Create the page. Source: MCT reading 4.1.3, p12, 01 March 2012.)
 
imported>Doug Williamson
(Added 1 line space before see also)
 
Line 1: Line 1:
Non-transferable risks are risks which must be borne by an organisation.  
#Payment.
 
#A generic term for a payment or a receipt.
 
Non-transferable risks might be avoided or accepted and retained or reduced as appropriate. In the case of non-transferable business risks (which by definition are not avoided) it is important that the firm has a distinctive competence in the relevant areas.  
 
For example, a pharmaceutical company's non-transferable risks would include the risk that failure to gain approval for use of a new drug means that the research and development costs have been wasted.
 




== See also ==
== See also ==
*[[Transferable risk]]
* [[Payment]]
* [[Receipt]]
* [[Remittance factory]]

Revision as of 10:04, 30 May 2015

  1. Payment.
  2. A generic term for a payment or a receipt.


See also